Global Pharmaceutical Contract Packaging Market, By Products (Flexible Packaging, Plastic Containers, Glass Containers and Caps/Closures), Drug Type (Autacoids and Related Drugs, Contraceptives, Hormone Replacement, Cardiovascular Medicines and Cancer Therapies), Drug Form (Injectable and Oral), Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile and Non-Sterile), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Pharmaceutical Contract Packaging Market
Pharmaceutical contract packaging market will grow at a rate of 13.42% for the forecast period of 2021 to 2028. Increase in the demand for sustainable packaging is an essential factor driving the medical polymers market.
Pharmaceutical contract packaging is referred to as outsourcing to third party suppliers of packaging operations. This helps them to save time and expenses and some of the common types of these packaging are plastic containers, glass containers, flexible packaging, caps, closures and others.
Rise in the number of new medicines in the market is the major factor escalating the market growth, also rise in the geriatric population, increase in the strict protocols associated with the packaging, increase in the demand for biological therapies, rise in the growth in the nuclear medicine sector and rise in the demand for cell and gene therapies are the major factors among others propelling the growth of pharmaceutical contract packaging market. Moreover, rise in the research and development activities to develop advanced plastics and increase in the development of patient-specific implants and 3D printed devices will further create new opportunities for the pharmaceutical contract packaging market in the in the forecast period of 2021- 2028.
However, rise in the risk associated with the poor quality of the product and restricted information sharing with contract packagers are the major factors among others restraining the market growth, and will further challenge the growth of pharmaceutical contract packaging market.
This pharmaceutical contract packaging market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on pharmaceutical contract packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Pharmaceutical Contract Packaging Market Scope and Market Size
Pharmaceutical contract packaging market is segmented on the basis of products, drug type, drug form, industry and type. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of products, pharmaceutical contract packaging market is segmented into flexible packaging, plastic containers, glass containers and caps/closures.
- On the basis of drug type, pharmaceutical contract packaging market is segmented into autacoids and related drugs, contraceptives, hormone replacement, cardiovascular medicines and cancer therapies.
- On the basis of drug form, pharmaceutical contract packaging market is segmented into injectable and oral.
- On the basis of industry, pharmaceutical contract packaging market is segmented into small molecule, biopharmaceutical, and vaccine.
- On the basis of type, pharmaceutical contract packaging market is segmented into sterile and non-sterile.
Pharmaceutical Contract Packaging Market Country Level Analysis
Pharmaceutical contract packaging market is analysed and market size, volume information is provided by products, drug type, drug form, industry and type as referenced above.
The countries covered in the pharmaceutical contract packaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates pharmaceutical contract packaging market due to rise in the geriatric population, increase in the strict protocols associated with the packaging and increase in the demand for biological therapies in this region. Asia-Pacific is the expected region in terms of growth in pharmaceutical contract packaging market due to increase in the strict protocols associated with the packaging and increase in the demand for biological therapies in this region.
The country section of the pharmaceutical contract packaging market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Pharmaceutical Contract Packaging Market Share Analysis
Pharmaceutical contract packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to pharmaceutical contract packaging market.
The major players covered in the pharmaceutical contract packaging market report are BALL CORPORATION, Berlin Packaging, CCL Industries, Co-Pak, Signode India, ROPACK INC, Reelvision, PCI Pharma Services, Multi-Pack Solutions LLC, Unicep, Sharp, Reed-Lane, Aphena Pharma Solutions, Southwest Packaging., Catalent, Inc, AbbVie Inc., Pfizer Inc., Daito Pharmaceutical Co.,Ltd., NIPRO, Cradel Pharmaceuticals Pvt. Ltd. and Gerresheimer AG among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-